Skip to content
Subscriber Only

Indonesia Approves China’s Sinovac Vaccine Use for Elderly

Vials of the Sinovac Covid-19 vaccine.

Vials of the Sinovac Covid-19 vaccine.

Photographer: Dimas Ardian/Bloomberg
Updated on

Indonesia approved Sinovac Biotech Ltd.’s Covid-19 vaccine for use on the elderly after receiving clinical trial results from China and Brazil at the end of January.

The clinical trials showed no reports of serious side effects on the use of the vaccine, according to Penny Lukito, head of Indonesia’s food and drug regulator. The first and second phase of clinical trials of the shot in China that involved 400 elderly people showed good results of increased amount of antibodies, she said in a briefing on Sunday.